Blockonomi

Legend Biotech (LEGN) Stock: CARVYKTI Revenue Soars 66% in Q4 with 2026 Profit Target

CARVYKTI Q4 sales surge 66% to $555M, manufacturing scales up, and company targets enterprise profitability by 2026.